#387 - AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field

Peptides function as short chains of amino acids that serve critical biological roles as signaling molecules and hormones, yet their current popularity in the biohacking and longevity communities often outpaces scientific consensus. Evaluating these compounds requires a rigorous framework that assesses the existence of a viable mechanism of action, human clinical evidence, safety profiles, and the availability of FDA-approved alternatives. While legitimate therapeutic peptides like insulin and GLP-1 agonists demonstrate clear clinical efficacy, many widely marketed, gray-market peptides lack robust human data or regulatory oversight. Distinguishing between scientifically grounded interventions and marketing hype is essential, as many substances sold for "research use only" lack the rigorous testing required for safe human application. Establishing a clear understanding of dosing, potential risks, and the underlying biological pathways remains the primary challenge for individuals navigating this complex and poorly regulated landscape.